IGBMC
Yuliia Moroziuk (Kovalchuk) is a PhD Candidate at IGBMC since December 2021, focusing on the role of histone variant H3.3 in epigenetic phenomena and tumorigenesis. Prior to this position, Yuliia served as an M2 Intern at CEA, where the functional characterization of the BAF complex in mESCs was investigated. Yuliia has also gained experience as a Research Intern at the Vancouver Prostate Centre, studying Neuroendocrine Prostate Cancer development, and held internships at Enamine Ltd. and the Institute of Molecular Biology and Genetics, NAS of Ukraine. Yuliia's educational background includes a Doctor of Philosophy in Epigenetics from the University of Strasbourg and various Master's and Bachelor's degrees in life sciences from Université Paris-Saclay and Taras Shevchenko National University of Kyiv.
This person is not in any teams
IGBMC
Created in 1994 by Pierre Chambon, one of the most important figures in biomedical research, the IGBMC is now one of the main European research centres in this domain. In France, it is the largest research unit, involving the CNRS, Inserm and the University of Strasbourg. In addition to its four scientific programs, the IGBMC has developed advanced scientific services and technological platforms for internal use, but also open to the wider scientific community. The Institute aims to develop interdisciplinary research at the interface of biology, biochemistry, physics and medicine, but also to attract students from around the world by offering very high-level education in the field of biomedical sciences. The IGBMC campus is located on the "Parc d'Innovation d'Illkirch" in the Strasbourg suburbs, which represents an exceptional scientific, academic and industrial environment and largely favours collaborations and technology transfer.